跳至主要内容
临床试验/ACTRN12623001323617
ACTRN12623001323617进行中(未招募)Unknown

Hypermobile Online Pain managemEnt (HOPE) for people with hypermobile Ehlers-Danlos Syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD): a pilot randomised controlled trial of feasibility, acceptability and effectiveness

Macquarie University0 个研究点目标入组 73 人开始时间: 2023年12月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults aged 18 and over
  • Australian residents
  • Diagnosed with hEDS or HSD or Joint Hypermobility Syndrome (JHS) or Ehlers-Danlos Syndrome – Hypermobility Type (EDS-HT) by a medical doctor (e.g. rheumatologist, geneticist, general practitioner)
  • Presence of pain for more than 3 months
  • Sufficient English proficiency to engage with program and interview
  • Have access to a desktop/laptop and internet over the course of the program
  • Stable dosage and type of pain medication in the last 3 months
  • Stable medical or allied health interventions for pain (such as Physiotherapy, Psychology) in the last 3 months

排除标准

  • Severe depression (Patient Health Questionnaire (PHQ-9) score >=20)
  • Significant suicidal ideation (PHQ-9 score >2 on item 9)
  • Co-existing medical conditions causing pain not known to be associated with hEDS/HSD such as active cancer, active inflammatory joint conditions

研究者

相似试验